17 September 2020
Bioanalysis is a crucial and ever-evolving field in the lifecycle of drug development for both small molecules and biologics. Defined as the processes by which scientists determine the concentration of a drug, their metabolite, or any pharmacodynamic biomarkers within a biological fluid sample.
8 June 2020
Changes, challenges & considerations: Leadership opinions resulting from the pandemic
Euromedica have been fortunate enough to speak with a broad array of industry leaders since the global pandemic began, each with their own opinions and takeaways from COVID-19.
18 March 2020
Biosimilar drugs deemed to be the ‘real deal’ in today’s Biopharmaceutical landscape
In the current financial climate, with National Health Services across Western countries under increasing pressure to ‘do more with less’, biosimilar drugs are starting to attract significant attention and are likely to reshape the pharmaceutical industry as we know it.
11 March 2020
Industry Executives - Q&A
Recently Dan Nathan, Managing Partner at Euromedica, spoke with Olivier Charmeil, Executive Committee member and EVP, General Medicines at Sanofi, as he moves into a new internal position and to share his insights on leadership within a transformational industry.
Get in touch to learn how we can add value to your business or career.